Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
KRE enters the week with a notable shift in its lending market, after one of the tightest borrow episodes of the past year.
The standout story is how quickly availability has swung. Just two weeks ago, availability fell as low as 0.44% on September 21, the tightest the borrow market has been in the past year, with every share in the lending pool effectively spoken for. By October 6, availability had recovered to 301%, meaning there are now roughly three shares available to borrow for every one already shorted. That is a dramatic loosening in a short period. Cost to borrow has ticked up alongside the recovery in supply, reaching 1.97% on October 6, up 31% on the week and a sharp jump from the near-zero readings briefly seen in early September. That cost is still modest in absolute terms, but the month-on-month change is striking: borrowing KRE was essentially free at the start of September, and is now running at levels that reflect genuine demand for the short.
Short interest itself remains structurally high, though it has eased a fraction. Shares short came in at roughly 59.6 million on October 6, down less than 1% on the day and down about half a percent on the week. Measured against the float, that is 112.7% of free float, a figure that reflects how ETF mechanics distort the headline number. For a large, liquid ETF like KRE, short interest routinely exceeds 100% of float because authorised participants can create and redeem shares continuously, making the float itself a moving target. The FINRA fortnightly figure, which captures a settlement-date snapshot, put shares short at 58.6 million as of September 15, consistent with the daily estimate. The days-to-cover reading of 4.67 is worth noting: at current trading volumes it would take nearly five days to cover the entire short book, a modest friction but not extreme for a major ETF.
The ORTEX short score, which aggregates the borrowing, positioning and flow signals, has eased from a peak of 74 in late September to 64 now, tracking the loosening in borrow conditions. That is still an elevated reading, placing KRE in territory where short pressure is above average, but the directional move lower over the past two weeks suggests the most acute phase of the squeeze, when availability was near zero and shorts were scrambling, has passed.
Options positioning remains structurally defensive, though less so than it was. The put/call ratio is 1.90, just below its 20-day mean of 1.94 and well within normal range by recent standards. The z-score of negative 0.44 puts it slightly below the recent average, meaning protective positioning has actually softened a touch this week even as the broader setup stays put-heavy. The 52-week range for the PCR runs from 1.45 to 2.46, so the current level is in the middle of that band. Options traders in KRE are characteristically cautious given regional banking's sensitivity to rate and credit-cycle risk, but there is no fresh surge in hedging demand this week.
The ETF itself closed at $70.07 on October 6, down 0.45% on the day but up 0.34% on the week. The month is a different picture: KRE is off nearly 7% over the past 30 days, and the squeeze episode in the lending market in mid-to-late September coincided with that price weakness. Regional banks continue to face pressure from margin compression, deposit competition, and uncertainty around the rate path, and the persistent short book reflects that the bear case on the sector has not gone away. What has changed is the mechanics: with availability now wide open, new shorts can be put on easily and cheaply, which removes one of the preconditions for a technically driven short squeeze. What to watch next is whether the loosening in availability draws fresh short sellers back in, or whether the easing of borrow pressure is the market telling a less bearish story about regional banks heading into Q3 earnings season.
See the live data behind this article on ORTEX.
Open KRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
